Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Orthopedic

PUBLISHER: Grand View Research | PRODUCT CODE: 1631185

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 1631185

Asia Pacific Bone Grafts & Substitutes Market Size, Share & Trends Analysis Report By Material Type (Allograft, Synthetic), By Application (Craniomaxillofacial, Dental), By Country, And Segment Forecasts, 2025 - 2030

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 4950
Printable PDF & Excel (5-User License)
USD 5950
Printable PDF & Excel (Enterprise License)
USD 7950

Add to Cart

Description

Table of Contents

List of Tables

Asia Pacific Bone Grafts & Substitutes Market Growth & Trends:

The Asia Pacific bone grafts & substitutes market size is estimated to reach USD 1.06 billion by 2030, expanding at a CAGR of 8.2% from 2025 to 2030, according to a new report by Grand View Research, Inc. Increasing the incidence of bone disorders due to road accidents and sports injuries is driving the market. Increasing demand for the development of biocompatible bone grafts in order to reduce adverse reaction is driving demand for synthetic grafts.

The industry players are continuously trying to develop new products with better biocompatibility, bioactivity, and suitable mechanical properties. For instance, in June 2019, Biogennix received 510(K) clearance from USFDA for Agilon, which is fully biocompatible with human bone. In August 2019, NanoFUSE biologics marked its presence in Thailand with FDA approved NanoFUSE biologics, a bioactive glass with a demineralized bone matrix.

Asia Pacific Bone Grafts & Substitutes Market Report Highlights:

  • In terms of revenue, the allograft segment dominated the market with a revenue share of 57.6% in 2024. The growth can be attributed to its increased usage in medical procedures and product innovation.
  • The Demineralized Bone Matrix (DBM) segment dominated the allografts segment as of 2024 owing to its increased commercial accessibility in a number of standard forms and sources.
  • On the basis of application, the spinal fusion segment held the largest revenue share in 2024 owing to the growing number of spinal fusion procedures and new product approvals for the same.
  • The dental segment is expected to show lucrative growth over the forecast period. The growth can be attributed to the increasing number of dental implant surgeries and product availability.
  • An increasing number of government initiatives and medical tourism is expected to propel market growth. Moreover, the growing number of bone and joint disorders due to the increasing aging population is further increasing the growth.
Show more
Product Code: GVR-4-68038-938-8

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Material Type
    • 1.2.2. Application
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Asia Pacific Bone Grafts & Substitutes Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Asia Pacific Bone Grafts & Substitutes Market: Material Type Business Analysis

  • 4.1. Material Type Market Share, 2024 & 2030
  • 4.2. Material Type Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Material Type, 2018 to 2030 (USD Million)
  • 4.4. Allograft
    • 4.4.1. Allograft Market, 2018 - 2030 (USD Million)
    • 4.4.2. Demineralized Bone Matrix
      • 4.4.2.1. Demineralized Bone Matrix Market, 2018 - 2030 (USD Million)
    • 4.4.3. Others
      • 4.4.3.1. Others Market, 2018 - 2030 (USD Million)
  • 4.5. Synthetic
    • 4.5.1. Synthetic Market, 2018 - 2030 (USD Million)
    • 4.5.2. Ceramics
      • 4.5.2.1. Ceramics Market, 2018 - 2030 (USD Million)
      • 4.5.2.2. HAP
        • 4.5.2.2.1. HAP Market, 2018 - 2030 (USD Million)
      • 4.5.2.3. B-TCP
        • 4.5.2.3.1. B-TCP Market, 2018 - 2030 (USD Million)
      • 4.5.2.4. a-TCP
        • 4.5.2.4.1. a-TCP Market, 2018 - 2030 (USD Million)
      • 4.5.2.5. bi-phasic calcium phosphates (BCP)
        • 4.5.2.5.1. bi-phasic calcium phosphates (BCP) Market, 2018 - 2030 (USD Million)
      • 4.5.2.6. Others
        • 4.5.2.6.1. Others Market, 2018 - 2030 (USD Million)
    • 4.5.3. Composites
      • 4.5.3.1. Composites Market, 2018 - 2030 (USD Million)
    • 4.5.4. Polymers
      • 4.5.4.1. Polymers Market, 2018 - 2030 (USD Million)
    • 4.5.5. Bone Morphogenic Proteins (BMP)
      • 4.5.5.1. Bone Morphogenic Proteins (BMP), 2018 - 2030 (USD Million)

Chapter 5. Asia Pacific Bone Grafts & Substitutes Market: Application Business Analysis

  • 5.1. Application Market Share, 2024 & 2030
  • 5.2. Application Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 5.4. Craniomaxillofacial
    • 5.4.1. Craniomaxillofacial Market, 2018 - 2030 (USD Million)
  • 5.5. Dental
    • 5.5.1. Dental Market, 2018 - 2030 (USD Million)
  • 5.6. Foot and Ankle
    • 5.6.1. Foot and Ankle Market, 2018 - 2030 (USD Million)
  • 5.7. Joint Reconstruction
    • 5.7.1. Joint Reconstruction Market, 2018 - 2030 (USD Million)
  • 5.8. Long Bone
    • 5.8.1. Long Bone Market, 2018 - 2030 (USD Million)
  • 5.9. Spinal Fusion
    • 5.9.1. Spinal Fusion Market, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. Baxter.
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Material Type Benchmarking
      • 6.5.1.4. Strategic Initiatives
    • 6.5.2. Medical Device Business Services, Inc.
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Material Type Benchmarking
      • 6.5.2.4. Strategic Initiatives
    • 6.5.3. NuVasive, Inc.
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Material Type Benchmarking
      • 6.5.3.4. Strategic Initiatives
    • 6.5.4. Stryker
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Material Type Benchmarking
      • 6.5.4.4. Strategic Initiatives
    • 6.5.5. Medtronic
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Material Type Benchmarking
      • 6.5.5.4. Strategic Initiatives
    • 6.5.6. Zimmer Biomet.
      • 6.5.6.1. Overview
      • 6.5.6.2. Financial Performance
      • 6.5.6.3. Material Type Benchmarking
      • 6.5.6.4. Strategic Initiatives
    • 6.5.7. Smith+Nephew
      • 6.5.7.1. Overview
      • 6.5.7.2. Financial Performance
      • 6.5.7.3. Material Type Benchmarking
      • 6.5.7.4. Strategic Initiatives
    • 6.5.8. Orthofix Medical Inc.
      • 6.5.8.1. Overview
      • 6.5.8.2. Financial Performance
      • 6.5.8.3. Material Type Benchmarking
      • 6.5.8.4. Strategic Initiatives
    • 6.5.9. Wright Medical Group N.V.
      • 6.5.9.1. Overview
      • 6.5.9.2. Financial Performance
      • 6.5.9.3. Material Type Benchmarking
      • 6.5.9.4. Strategic Initiatives
    • 6.5.10. Geistlich Pharma AG
      • 6.5.10.1. Overview
      • 6.5.10.2. Financial Performance
      • 6.5.10.3. Material Type Benchmarking
      • 6.5.10.4. Strategic Initiatives
Show more
Product Code: GVR-4-68038-938-8

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Asia Pacific bone grafts & substitutes market, by country, 2018 - 2030 (USD Million)
  • Table 4 Asia Pacific bone grafts & substitutes market, by material type, 2018 - 2030 (USD Million)
  • Table 5 Asia Pacific bone grafts & substitutes market, by application, 2018 - 2030 (USD Million)
  • Table 6 China bone grafts & substitutes market, by material type, 2018 - 2030 (USD Million)
  • Table 7 China bone grafts & substitutes market, by application, 2018 - 2030 (USD Million)
  • Table 8 Japan bone grafts & substitutes market, by material type, 2018 - 2030 (USD Million)
  • Table 9 Japan bone grafts & substitutes market, by application, 2018 - 2030 (USD Million)
  • Table 10 India bone grafts & substitutes market, by material type, 2018 - 2030 (USD Million)
  • Table 11 India bone grafts & substitutes market, by application, 2018 - 2030 (USD Million)
  • Table 12 South Korea bone grafts & substitutes market, by material type, 2018 - 2030 (USD Million)
  • Table 13 South Korea bone grafts & substitutes market, by application, 2018 - 2030 (USD Million)
  • Table 14 Australia bone grafts & substitutes market, by material type, 2018 - 2030 (USD Million)
  • Table 15 Australia bone grafts & substitutes market, by application, 2018 - 2030 (USD Million)
  • Table 16 Thailand bone grafts & substitutes market, by material type, 2018 - 2030 (USD Million)
  • Table 17 Thailand bone grafts & substitutes market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Asia Pacific bone grafts & substitutes market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Material Type outlook (USD Million)
  • Fig. 10 Application outlook (USD Million)
  • Fig. 11 Competitive landscape
  • Fig. 12 Asia Pacific bone grafts & substitutes market dynamics
  • Fig. 13 Asia Pacific bone grafts & substitutes market: Porter's five forces analysis
  • Fig. 14 Asia Pacific bone grafts & substitutes market: PESTLE analysis
  • Fig. 15 Asia Pacific bone grafts & substitutes market: Material Type segment dashboard
  • Fig. 16 Asia Pacific bone grafts & substitutes market: Material Type market share analysis, 2024 & 2030
  • Fig. 17 Allograft market, 2018 - 2030 (USD Million)
  • Fig. 18 Demineralized bone matrix market, 2018 - 2030 (USD Million)
  • Fig. 19 Others market, 2018 - 2030 (USD Million)
  • Fig. 20 Synthetic market, 2018 - 2030 (USD Million)
  • Fig. 21 Ceramics market, 2018 - 2030 (USD Million)
  • Fig. 22 HAP market, 2018 - 2030 (USD Million)
  • Fig. 23 B-TCP market, 2018 - 2030 (USD Million)
  • Fig. 24 a-TCP market, 2018 - 2030 (USD Million)
  • Fig. 25 bi-phasic calcium phosphates (BCP) market, 2018 - 2030 (USD Million)
  • Fig. 26 Others market, 2018 - 2030 (USD Million)
  • Fig. 27 Composites market, 2018 - 2030 (USD Million)
  • Fig. 28 Polymers market, 2018 - 2030 (USD Million)
  • Fig. 29 Bone morphogenic proteins (BMP) market, 2018 - 2030 (USD Million)
  • Fig. 30 Asia Pacific bone grafts & substitutes market: Application segment dashboard
  • Fig. 31 Asia Pacific bone grafts & substitutes market: Application market share analysis, 2024 & 2030
  • Fig. 32 Craniomaxillofacial market, 2018 - 2030 (USD Million)
  • Fig. 33 Dental market, 2018 - 2030 (USD Million)
  • Fig. 34 Foot and ankle market, 2018 - 2030 (USD Million)
  • Fig. 35 Joint reconstruction market, 2018 - 2030 (USD Million)
  • Fig. 36 Long bone market, 2018 - 2030 (USD Million)
  • Fig. 37 Spinal fusion market, 2018 - 2030 (USD Million)
  • Fig. 38 Company categorization
  • Fig. 39 Company market position analysis
  • Fig. 40 Strategic framework
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!